These are estimates for the 2025 reporting year, published in July 2026. The earlier version of this article discussed mainly 2024 data under a 2025 headline. Updating the data requires updating the year and definition together.
First-dose access and completion answer different questions
The 15 July 2026 joint release gives DTP1 coverage of 90%, around 116 million infants, and DTP3 coverage of 85%, around 110 million. The difference indicates that reaching children once and completing a multi-dose series remain separate challenges. It should not be described simply as one vaccination rate.
Completion of a reported series is also not a direct count of children fully protected against every relevant disease. Coverage records receipt of a specified dose in a specified target population. Protection and disease outcomes involve additional questions, including the vaccine, schedule and circumstances.
HPV coverage uses a different population and dose
The WHO immunization coverage factsheet reports global first-dose HPV coverage among girls of 33% in 2025. That figure should not be compared as though it were the same indicator as three-dose DTP coverage among infants. The age group, disease and dose definition differ.
Vaccine composition is a separate measure again. Our explanation of the 2026–2027 US flu formulation follows the selection of virus representatives; it does not measure childhood vaccination coverage or replace the dose-specific figures discussed here.
An increase in first-dose coverage is valuable information, but it does not automatically describe completion under every national schedule. A comparison across countries should use the same eligible cohort and dose definition, rather than combine whichever national percentage is easiest to find.
Use one release when comparing years
The 2026 joint release describes a one-percentage-point rise in both DTP indicators against its estimate for the previous year. Historical estimates can be revised between annual releases. Subtracting a rounded 2024 figure copied from an older news story from a 2025 figure in the new release can therefore produce an apparent contradiction.
For a reproducible trend, use the historical series accompanying the same release and record its publication date. A change from 84% to 85%, for example, is one percentage point; this arithmetic example is not an additional country estimate. A relative percentage increase is a different calculation and should be labelled as such.
Global averages do not describe every community
The UNICEF immunization data overview reports 19.6 million children as unvaccinated or under-vaccinated in 2025. It also gives the separate 13.5 million zero-dose estimate. These groups overlap and must not be added as though they were independent populations.
A country average can hide differences in access within its population. Conversely, a local outbreak or a national figure with no specified age or vaccine cannot establish the global trend. The earlier unsourced Australian 92.9% comparison and loosely dated outbreak totals have been removed rather than assigned an invented definition.
The useful reading habit is to keep the vaccine, dose, target population, reporting year and release date beside each percentage. That makes it possible to identify the actual access or completion problem without turning a collection of unlike numbers into a claim of universal progress.
